Hutchison China Meditech
World Rank (Aug-2026)
5,578
Market Cap (Aug-2026)
2.522 Billion USD
World Rank (Jan-05-2024)
4,263
Market Cap (Jan-05-2024)
3.110 Billion USD
World Rank (Jul-30-2023)
4,768
Market Cap (Jul-30-2023)
2.625 Billion USD
World Rank (Dec-25-2022)
4,511
Market Cap (Dec-25-2022)
2.635 Billion USD
World Rank (Jan-07-2022)
2,820
Market Cap (Jan-07-2022)
6.03 Billion USD
Annual Revenue in USD
356 Million USD
Annual Net Income in USD
-194 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Hutchison China Meditech is an innovative, commercial stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The headquarters is in Hong Kong.
Company Website